Cooperatieve Gilde Healthcare IV U.A. - Oct 13, 2025 Form 4 Insider Report for LAVA Therapeutics NV (LVTX)

Role
10%+ Owner
Signature
Cooperatieve Gilde Healthcare IV U.A., By: /s/ Edwin de Graaf, Managing Director
Stock symbol
LVTX
Transactions as of
Oct 13, 2025
Transactions value $
-$718,721
Form type
4
Date filed
10/15/2025, 08:56 PM
Previous filing
Oct 10, 2025
Next filing
Oct 20, 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
Cooperatieve Gilde Healthcare IV U.A. 10%+ Owner STADSPLATEAU 36, UTRECHT, NETHERLANDS Cooperatieve Gilde Healthcare IV U.A., By: /s/ Edwin de Graaf, Managing Director 2025-10-15 0001756335
Gilde Healthcare Holding B.V. 10%+ Owner STADSPLATEAU 36, UTRECHT, NETHERLANDS Gilde Healthcare IV Management B.V., By: /s/ Edwin de Graaf, Managing Director 2025-10-15 0001420106

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LVTX Common Shares Sale -$73.4K -47.7K -0.9% $1.54 5.25M Oct 13, 2025 Direct F1, F2
transaction LVTX Common Shares Sale -$343K -227K -4.33% $1.51 5.02M Oct 14, 2025 Direct F2, F3
transaction LVTX Common Shares Sale -$302K -200K -3.98% $1.51 4.82M Oct 15, 2015 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This figure is the weighted average sales price of multiple trades ranging from $1.53 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F2 The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.
F3 This figure is the weighted average sales price of multiple trades ranging from $1.50 to $1.55 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.
F4 This figure is the weighted average sales price of multiple trades ranging from $1.49 to $1.54 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, LAVA Therapeutics NV or any security holder of LAVA Therapeutics NV full information about the number of shares sold at each separate price upon request.